New one-year results from 413 patients in the global EXPAND study of Abbott’s next-generation MitraClip mitral valve repair system demonstrate the benefits of MitraClip in a broad population of patients with functional (secondary) mitral regurgitation (MR).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?